Activity of different bicyclam derivatives against human immunodeficiency virus depends on their interaction with the CXCR4 chemokine receptor
about
Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1The CXCR4 antagonist AMD3100 efficiently inhibits cell-surface-expressed human immunodeficiency virus type 1 envelope-induced apoptosisOxovanadium(IV) cyclam and bicyclam complexes: potential CXCR4 receptor antagonists.Protein recognition of macrocycles: binding of anti-HIV metallocyclams to lysozyme.Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers.Therapeutic strategies underpinning the development of novel techniques for the treatment of HIV infection.Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropismCXC-chemokine receptor 4 antagonist AMD3100 promotes cardiac functional recovery after ischemia/reperfusion injury via endothelial nitric oxide synthase-dependent mechanism.Phospholipids showing complex bilayer phase transitions. II. Four sulfur-containing phosphatidylcholinesHuman Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment.Binding optimization through coordination chemistry: CXCR4 chemokine receptor antagonists from ultrarigid metal complexes.Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist.In vivo CXCR4 expression, lymphoid cell phenotype, and feline immunodeficiency virus infection.Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replication.Aspartate-Based CXCR4 Chemokine Receptor Binding of Cross-Bridged Tetraazamacrocyclic Copper(II) and Zinc(II) Complexes.
P2860
Q24673389-918DB1A7-D86B-4016-B567-49836418604BQ28343812-81A913DD-4020-41B0-AB7A-77B9A1A7C889Q33639946-D8281203-9370-4002-A924-08347101D9B5Q33850234-077B6E84-EB1F-4AC7-B4AE-730F50677078Q33979799-0CFF3026-179E-4D4E-ADC8-C5B82EA63FD6Q34021729-D9ECE456-0C60-439F-A6F1-14614A48EECCQ35635933-A632BB3B-1F05-4C0D-8FFC-B1742BB3955FQ36576314-29B1EA2B-A782-4A6F-931B-6405799AC35BQ36578038-12F76454-FFCF-4BA2-9A8F-779478ED4FA1Q37102101-B9D85241-635D-4AD1-93CE-EECCFC6AB61FQ37187072-9B8E98EE-D917-4BA3-97C0-D210CB5C66F8Q37596456-86FB873B-BBF0-4DC8-A58C-4C94006C5D96Q39038623-94A126CE-503E-4323-8366-C0C395165239Q39595136-B48BCE58-EC1A-4E55-AC74-EA462587C0B5Q40599515-196B3B6B-EA8B-4E05-8026-ECD1807C90AE
P2860
Activity of different bicyclam derivatives against human immunodeficiency virus depends on their interaction with the CXCR4 chemokine receptor
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Activity of different bicyclam ...... h the CXCR4 chemokine receptor
@ast
Activity of different bicyclam ...... h the CXCR4 chemokine receptor
@en
Activity of different bicyclam ...... h the CXCR4 chemokine receptor
@nl
type
label
Activity of different bicyclam ...... h the CXCR4 chemokine receptor
@ast
Activity of different bicyclam ...... h the CXCR4 chemokine receptor
@en
Activity of different bicyclam ...... h the CXCR4 chemokine receptor
@nl
prefLabel
Activity of different bicyclam ...... h the CXCR4 chemokine receptor
@ast
Activity of different bicyclam ...... h the CXCR4 chemokine receptor
@en
Activity of different bicyclam ...... h the CXCR4 chemokine receptor
@nl
P2093
P356
P1476
Activity of different bicyclam ...... h the CXCR4 chemokine receptor
@en
P2093
E De Clercq
J Van Damme
M J Abrams
R T Skerlj
P356
10.1124/MOL.55.1.67
P407
P577
1999-01-01T00:00:00Z